Aptevo Therapeutics Inc — Cash Flow (NASDAQ:APVO) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -29.32 M-21.68 M-21.02 M-11.73 M-23.79 M-25.59 M -25.59 M Cash from investing activities 28.03 M-713 K-29 K-29 K00 — Cash from financing activities 23.87 M26.16 M-2.62 M6 M15.6 M38.5 M 38.5 M Free cash flow -29.41 M-22.39 M-21.05 M-11.73 M-23.79 M-25.59 M -25.59 M

Haberler

Aptevo Therapeutics (APVO) Upgraded to Buy: Here's Why

Olumlu deneme verilerine rağmen Aptevo hisseleri düştü

Aptevo Therapeutics stock tumbles despite positive trial data

Aptevo Therapeutics announces leadership changes as CEO retires

Aptevo Therapeutics hisseleri 60 milyon dolarlık sermaye hattı anlaşmasıyla yükseldi

Aptevo Therapeutics stock jumps after securing $60 million equity line

Aptevo, operasyonları finanse etmek için 60 milyon dolarlık kredi hattı sağladı

Aptevo secures $60 million equity line of credit to fund operations

Aptevo Therapeutics 1’e 18 ters hisse bölünmesi gerçekleştirdi

Aptevo Therapeutics enacts 1-for-18 reverse stock split, shares to trade on split-adjusted basis

Upcoming Stock Splits This Week (December 29 to January 2) – Stay Invested - TipRanks.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.04%